2-(3-Bromophenyl)imidazo[2,1-b]oxazole

Author:

Cores Ángel1ORCID,Villacampa Mercedes1ORCID,Menéndez J. Carlos1ORCID

Affiliation:

1. Unidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, Plaza de Ramón y Cajal, s.n., 28040 Madrid, Spain

Abstract

The microwave-assisted reaction of 2-nitroimidazole with 3-bromophenacyl bromide in the presence of potassium carbonate as a base and dimethylformamide as a solvent afforded 2-(3-bromophenyl)imidazo[2,1-b]oxazole. The formation of this compound was explained via a domino mechanism comprising an initial N-alkylation reaction of the imidazole substrate, followed by the base-promoted deprotonation of the position adjacent to the carbonyl to give an enolate anion that finally cyclizes via an intramolecular SNAr reaction, with the loss of the nitro group as potassium nitrite. Then, the proposed 1-(3-bromophenacyl)-2-nitroimidazole intermediate could be isolated by reducing the reaction time and was shown to be a precursor of the imidazo[2,1-b]oxazole final product.

Funder

Ministerio de Ciencia e Innovación, Spain

Publisher

MDPI AG

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Reference9 articles.

1. Kim, C.H., Baek, Y.M., Park, H.C., Lee, C.J., Shin, J.Y., Lee, J.H., and Cho, H.S. (2015). Preparation of Condensed Imidazoindole Compounds as Organic Electroluminescent Device Materials. (KR2015034029), Korean Patent.

2. Ashwell, M.A., Tandon, M., and Lapierre, J.-M. Synthesis of Imidazooxazole and Imidazothazole Inhibitors of p38 MAP Kinase. (8,178,672 B2), US Patent.

3. Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors;Ammar;Bioorg. Chem.,2019

4. Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies;Liang;Eur. J. Med. Chem.,2019

5. Novel imidazo[2,1-b]oxazole derivatives inhibit epithelial cell transformation and triple negative breast cancer tumorigenesis;Bhattarai;Anticancer Res.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3